NVWM LLC
CYTK icon

NVWM LLC’s Cytokinetics CYTK Stock Holding History

NVWM LLC’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$633K Buy
9,600
+477
+5% +$36.4K 0.12% 165
2026
Q2 		$777K Sell
9,123
-94
-1% -$6.75K 0.16% 145
2026
Q1 		$607K Buy
+9,217
New +$586K 0.14% 163

Other funds holding CYTK

Polaris Capital Management
Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return
E. Ohman J:or Asset Management
E. Ohman J:or Asset Management Stockholm, Sweden $4.47B AUM 27.58% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
Mirador Capital Partners
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Amalgamated Bank
Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
Yousif Capital Management
Yousif Capital Management Bloomfield Hills, Michigan $8.87B AUM 34.1% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

NVWM LLC's CYTK Position: Q3 2026 in Review

NVWM LLC increased its Cytokinetics (CYTK) stake by 5.2% in Q3 2026, buying an estimated $36.4K and bringing the position to 9,600 shares worth $633K. The position accounts for 0.12% of the portfolio, ranked #165.

NVWM LLC first reported a position in CYTK in Q1 2026 and has held it in 3 quarters since. The position peaked at $777K in Q2 2026. 60 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.

  • NVWM LLC held 9,600 shares of Cytokinetics worth $633K as of Q3 2026.
  • NVWM LLC bought 477 Cytokinetics shares in Q3 2026, an estimated $36.4K.
  • Cytokinetics made up 0.12% of NVWM LLC's portfolio in Q3 2026, its #165 holding.
  • NVWM LLC first reported a position in Cytokinetics in Q1 2026 and has held it in 3 quarters since.
  • NVWM LLC's Cytokinetics position peaked at $777K in Q2 2026.
  • 60 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.

Based on NVWM LLC's 13F filing for Q3 2026, filed 14 Oct 2026.